Repository logoGCRIS
  • English
  • Türkçe
  • Русский
Log In
New user? Click here to register. Have you forgotten your password?
Home
Communities
Browse GCRIS
Entities
Overview
GCRIS Guide
  1. Home
  2. Browse by Author

Browsing by Author "Ozdemir, Ibrahim"

Filter results by typing the first few letters
Now showing 1 - 4 of 4
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Article
    Citation - WoS: 5
    Citation - Scopus: 2
    Prevalence and Associated Factors of Inappropriate Dosing of Direct Oral Anticoagulants in Patients With Atrial Fibrillation: the Anatolia-Af Study
    (Springer, 2022-12-17) Kocabas, Umut; Ergin, Isil; Yavuz, Veysel; Murat, Selda; Ozdemir, Ibrahim; Genc, Omer; Altin, Cihan; Ozcalik, Emre
    Purpose Inappropriate dosing of direct oral anticoagulants is associated with an increased risk of stroke, systemic embolism, major bleeding, cardiovascular hospitalization, and death in patients with atrial fibrillation. The main goal of the study was to determine the prevalence and associated factors of inappropriate dosing of direct oral anticoagulants in real-life settings.Methods This study was a multicenter, cross-sectional, observational study that included 2004 patients with atrial fibrillation. The study population was recruited from 41 cardiology outpatient clinics between January and May 2021. The main criteria for inappropriate direct oral anticoagulant dosing were defined according to the recommendations of the European Heart Rhythm Association.Results The median age of the study population was 72 years and 58% were women. Nine-hundred and eighty-seven patients were prescribed rivaroxaban, 658 apixaban, 239 edoxaban, and 120 dabigatran. A total of 498 patients (24.9%) did not receive the appropriate dose of direct oral anticoagulants. In a logistic regression model, advanced age, presence of chronic kidney disease and permanent atrial fibrillation, prescription of reduced doses of direct oral anticoagulants or edoxaban treatment, concomitant use of amiodarone treatment, and non-use of statin treatment were significantly associated with potentially inappropriate dosing of direct oral anticoagulants.Conclusion The study demonstrated that the prevalence of inappropriate direct oral anticoagulant dosing according to the European Heart Rhythm Association recommendations was 24.9% in patients with atrial fibrillation. Several demographic and clinical factors were associated with the inappropriate prescription of direct oral anticoagulants.
  • Loading...
    Thumbnail Image
    Correction
    Citation - WoS: 1
    Prevalence and Associated Factors of Inappropriate Dosing of Direct Oral Anticoagulants in Patients With Atrial Fibrillation: the Anatolia-Af Study (dec, 10.1007/S10557-022-07409-w, 2022)
    (Springer, 2023-01-19) Kocabas, Umut; Ergin, Isil; Yavuz, Veysel; Murat, Selda; Ozdemir, Ibrahim; Genc, Omer; Altin, Cihan; Özçalık, Emre
    [Abstract Not Available]
  • Loading...
    Thumbnail Image
    Conference Object
    Prevalence and Associated Factors of Inappropriate Dosing of Direct Oral Anticoagulants in Patients With Atrial Fibrillation: the Anatolia-Af Study [pp. 59-61]
    (Kare Publ, 2022-12-17) Kocabas, Umut; Ergin, Isil; Yavuz, Veysel; Murat, Selda; Ozdemir, Ibrahim; Genc, Omer; Altin, Cihan; Okar, Sefa
    [Abstract Not Available]
  • Loading...
    Thumbnail Image
    Conference Object
    Real-World Evaluation of Anticoagulant Treatment Patterns in Patients With Atrial Fibrillation: Data From Multicenter Rota Study [2022]
    (Kare Publ, 2023) Kocabas, Umut; Ergin, Isil; Yavuz, Veysel; Murat, Selda; Ozdemir, Ibrahim; Genc, Omer; Altin, Cihan; Özçalık, Emre; Şengör, Büşra Güvendi; Sen, Taner; Kaplan, Mehmet; Dal, Ahmet; Dogdus, Mustafa; Şahin, Şeyda
    [Abstract Not Available]
Repository logo
Collections
  • Scopus Collection
  • WoS Collection
  • TrDizin Collection
  • PubMed Collection
Entities
  • Research Outputs
  • Organizations
  • Researchers
  • Projects
  • Awards
  • Equipments
  • Events
About
  • Contact
  • GCRIS
  • Research Ecosystems
  • Feedback
  • OAI-PMH

Log in to GCRIS Dashboard

GCRIS Mobile

Download GCRIS Mobile on the App StoreGet GCRIS Mobile on Google Play

Powered by Research Ecosystems

  • Privacy policy
  • End User Agreement
  • Feedback